JPWO2022039190A1 - - Google Patents
Info
- Publication number
- JPWO2022039190A1 JPWO2022039190A1 JP2022543971A JP2022543971A JPWO2022039190A1 JP WO2022039190 A1 JPWO2022039190 A1 JP WO2022039190A1 JP 2022543971 A JP2022543971 A JP 2022543971A JP 2022543971 A JP2022543971 A JP 2022543971A JP WO2022039190 A1 JPWO2022039190 A1 JP WO2022039190A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020138157 | 2020-08-18 | ||
PCT/JP2021/030165 WO2022039190A1 (ja) | 2020-08-18 | 2021-08-18 | サーチュイン活性化剤及びサーチュイン活性化方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2022039190A1 true JPWO2022039190A1 (ja) | 2022-02-24 |
Family
ID=80350397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022543971A Pending JPWO2022039190A1 (ja) | 2020-08-18 | 2021-08-18 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20230310355A1 (ja) |
EP (1) | EP4209211A1 (ja) |
JP (1) | JPWO2022039190A1 (ja) |
WO (1) | WO2022039190A1 (ja) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69529043T2 (de) * | 1994-09-30 | 2003-05-08 | Oreal | Verwendung von einem Agonisten eines mit einem Chloridkanal assozierten Rezeptors zur Behandlung von Hautfalten |
US20060039935A1 (en) * | 2004-08-20 | 2006-02-23 | Mr. Stanley Antosh | Composition of a transdermal delivery system, which modulates inflammation, via insitu systems, thereby promoting repair of injured, damaged or diseased joints, and soft tissue. |
CA2649477C (en) * | 2008-04-18 | 2016-04-19 | Nuvocare Health Sciences Inc. | Composition and method for promoting internal health and external appearance |
JP2011057580A (ja) | 2009-09-08 | 2011-03-24 | Fancl Corp | サーチュイン活性促進剤 |
JP5979810B2 (ja) | 2009-10-09 | 2016-08-31 | 株式会社山田養蜂場本社 | 抗老化剤 |
JP6403039B2 (ja) * | 2013-11-19 | 2018-10-10 | 国立大学法人九州大学 | Sirt3およびsirt6の活性化剤 |
WO2020160619A1 (en) * | 2019-02-05 | 2020-08-13 | Helium 3 Biotech Pty Ltd | A glycation reducing composition and method of use thereof |
-
2021
- 2021-08-18 WO PCT/JP2021/030165 patent/WO2022039190A1/ja unknown
- 2021-08-18 EP EP21858334.2A patent/EP4209211A1/en active Pending
- 2021-08-18 US US18/041,730 patent/US20230310355A1/en active Pending
- 2021-08-18 JP JP2022543971A patent/JPWO2022039190A1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4209211A1 (en) | 2023-07-12 |
US20230310355A1 (en) | 2023-10-05 |
WO2022039190A1 (ja) | 2022-02-24 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230215 |